Search

everythinglearnresearchcommunity

for

Search:↓

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

People with depression often have higher hair cortisol levels, while those with PTSD tend to have lower levels, but more research is needed to understand this fully.

Systemic retinoids may effectively treat erosive pustular dermatosis of the scalp.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.